Birch Grove Capital LP
Follow13F filer, CIK 1652355, New York, NY
Birch Grove Capital LP reported $9,954,966 across 4 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-24-002206
- Period
- 2024-06-30
- Reported value
- $9.95M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 3
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MULTIPLAN CORPORATIONexited | -75,000 | -$7.5K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2024
Share positions as resolved from 13F-HR 0000950142-24-002206, largest first. % of portfolio is the value over $9,123,311, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CHURCHILL CAPITAL CORP VIICHURCHILL CAPITAL CORP VII | 80,000 | $28.4K | 0.31% | 0 |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| MITEK SYS INCMITEK SYS INC NOTE 0.750% 2/0 | principal | 9,382,000 | $9.09M | 0 |
Sold out in Q2 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC | 6,000,000 | $3.21M | principal |
| THE REALREAL INCTHE REALREAL INC | 3,218,000 | $1.13M | principal |
| MULTIPLAN CORPORATIONMULTIPLAN CORPORATION | 75,000 | $7.5K | shares |
How Q2 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950142-24-002206 | base | 2024-08-14 | acceptance time not in the bulk data set |